Success Stories: With Premium Processing Upgrade, NIW Approval Made Easy for a Pediatric Resident in Biotechnologies from Greece, Thanks to Our Teamwork

Client’s Testimonial:

“This is fantastic news, thank you so much for your help!!”

On February 22^nd, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Pediatrics Resident in the Field of Biotechnologies (Approval Notice).

General Field: Biotechnologies

Position at the Time of Case Filing: Pediatrics Resident

Country of Origin: Greece

State of Residence at the Time of Filing: District of Columbia

Approval Notice Date: February 22^nd, 2023

Processing Time: 14 days (Premium Processing Requested)

Case Summary:

An expert in biotechnologies from Greece hired our services for his National Interest Waiver case. He held a Ph.D. in human genetics and was a pediatrics resident with years of experience at his back. His proposed endeavor was to work on the genetic basis and molecular pathogenesis of pediatric disorders to develop novel and efficient diagnostic methods and therapeutic treatments. So while getting his petition together we made a note of the following relevant information:

His work was of great importance because it provided crucial insight into the genetic mutations and molecular mechanisms underlying the development of a range of rare genetic pediatric disorders and schizophrenia, offering biotechnicians and clinicians the necessary data to develop both effective diagnostic tools and targeted treatment regimens for these conditions.
This proposed endeavor also had broad implications for the United States since genetic disorders caused by mutations in the DNA are a common cause of pediatric morbidity in the country.
Due to its clear national importance, his work found funding support from the National Institute of General Medical Sciences, the Burroughs Wellcome Fund, the Louma G Foundation, and the National Institute of Mental Health.
He had also completed at least 4 reviews to date and his work had resulted in 9 peer-reviewed journal articles (2 of them first-authored and 1 co-first authored).
His publications have also been cited a total of 162 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of biotechnologies.
Additionally, he also got 4 letters of recommendation from experts who knew his value and understood the importance of his work for the country. One of them wrote:

“[The client] is conducting key research into diagnosing rare genetic disorders that marks him as a leader in the field of biotechnologies. The research that [the client] is conducting into novel diagnostic techniques is therefore important. He has demonstrated an ability to develop new techniques that shed light on many complicated genetic disorders. With these techniques in hand, global healthcare providers have a new tool to bring down the costs of undiagnosed genetic conditions.”

These factors and his 4 years of work experience helped a great deal in winning his case quickly. The premium processing upgrade also aided in getting the approval in just 14 days. We thank our client for his trust in our firm and we wish him the best of luck for his future.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.